A new study led by Julia Slejko, PhD, associate professor in the Department of Practice, Sciences, and Health Outcomes Research (P-SHOR) at the University of Maryland School of Pharmacy (UMSOP), suggests that a large majority of Americans may be willing to prioritize improving health outcomes for socially disadvantaged groups — even if it means forgoing some gains in overall population health, based on the data from their study sample.
Published in Value in Health, the open-access study titled “Health Inequality Aversion in the United States” offers new insight into how the U.S. public values equity in health care decision-making.
Read the full story at the School of Pharmacy's News Center.